Bright Minds Biosciences : to Present at the Oppenheimer 32nd Annual Healthcare Conference

Published on

A biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Company management will present virtually at the Oppenheimer 32nd Annual Healthcare Conference.

Published on Bright Minds Biosciences, Biotecnology Company Canada, Mental Health Care, Psychedelic Company Stocks

To be informed of the latest articles, subscribe:
You might also like:
Why is mental health wellbeing important?
Why is mental health wellbeing important?
Bright Minds Biosciences' Serotonin Drug Targets Neuropsychiatric Disorders
Bright Minds Biosciences' Serotonin Drug Targets Neuropsychiatric Disorders
Suffering From Depressing? Tips To Help You Get Through
Suffering From Depressing? Tips To Help You Get Through
Immediate Treatment for Stress And Anxiety With Provided Psychedelic Drugs
Immediate Treatment for Stress And Anxiety With Provided Psychedelic Drugs
Immediate Treatment for Stress And Anxiety With Provided Psychedelic Drugs
How Psychedelic Drugs Can Transform Mental Health Care Industry?
Comment on this post